Artemis Gold Inc (ARTG)
TSX Venture Exchange · Canada · prices in CAD · close of 22 Oct 2026
Key indicators
| Last close | CAD 38.03 |
|---|---|
| 52-week range | 29.13 – 48.80 |
| Return, 1 month / 3 months | −8.6% / +8.8% |
| Return, 1 year / 3 years | +12.7% / +601.3% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 53.1% |
| Worst drawdown (1 year) | -36.7% |
| Average daily value traded | 9.80M CAD |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Artemis Gold Inc is a Canadian mining company focused on developing and operating gold mines. Its principal asset is the Blackwater project, a gold and silver mine in central British Columbia, where the company builds and runs open-pit operations and processing facilities. The company is based in Vancouver and works with contractors, suppliers and local communities in the region to extract and process ore into gold doré for refining and sale.
The shares are listed on the TSX Venture Exchange in Canada under the code ARTG, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Artemis Gold Inc (ARTG) trades on the TSX Venture Exchange in Canada. It last closed at CAD 38.03 on 22 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 132 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.7% and over the last three months it rose 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 82 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 1.4% | ||
| From 52-week high | -18.2% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.8% | ||
| 6-month return | -2.7% | ||
| 12-month return, skipping the last month | 23.2% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.7% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 9.80M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 6 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 1 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −4.2% |
|---|---|
| 1 month | −8.6% |
| 3 months | +8.8% |
| 6 months | −2.7% |
| 1 year | +12.7% |
| 3 years | +601.3% |
| 5 years | +508.3% |
Signals
| 50-day / 200-day average | 40.31 / 37.51 |
|---|---|
| Golden / death cross (60 days) | Golden, 30 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Aug 2026 | CAD 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.